From Google Scholar+ [to 10 August 2013]

From Google Scholar & other sources: Selected Journal Articles, Newsletters, Dissertations, Theses, Commentary

Prevention and control of influenza and dengue through vaccine development.
DP Greenberg, CA Robertson, DM Gordon – Pediatric annals, 2013
CME EDUCATIONAL OBJECTIVES 1. Review the impact of influenza infection in the pediatric population. 2. Discuss the importance of influenza B as a key cause of morbidity
and review the progress on development and deployment of quadrivalent influenza …

P5. 106 Charting the Path For Human Papillomavirus (HPV) Vaccine Introduction in Kenya: Assessing HPV Vaccine Acceptability Among Caregivers and Opinion …
AL Friedman, E Dunne, K Onyango, M Habel, J Ford… – Sexually Transmitted …, 2013
Background Cervical cancer is the second most common cancer diagnosed, and the leading cause of cancer-related mortality among women in Kenya. Kenya’s Ministry of Health has outlined new prevention strategies, including support for vaccination. Formative research …

P3. 369 Acceptability of HPV Tetravalent Vaccine Among Males Attending the STD Clinic of Milan-The Importance of the Costs For Patients
M Cusini, S Ramoni – Sexually Transmitted Infections, 2013
Background HPV infection is usually transmitted by sexual contact and represent the most prevalent sexually transmitted infection all over the world. The clinical spectrum of HPV
infection varies from the asymptomatic status to benign genital lesions to the development …

1 5 Chronic Non-Communicable
KMV NARAYAN, D YACH – Social Injustice and Public Health, 2013
… In recent years, new private foundations have appropriately invested billions of dollars for HIV/AIDS, malaria, tuberculosis, and immunizable diseases. And international donor organizations have increased support for tobacco control. …

The Hepatitis B Vaccine Protects Re-Exposed Healthcare Workers, but Does Not Provide Sterilizing Immunity
JM Werner, A Abdalla, N Gara, MG Ghany… – Gastroenterology, 2013
Background & Aims: Infection with hepatitis B virus (HBV) can be prevented by vaccination with HBV surface (HBs) antigen, which induces HBs-specific antibodies and T cells.
However, the duration of vaccine-induced protective immunity is poorly defined for …

Interview: An insight into cutting-edge tuberculosis vaccine research
EM Agger – Immunotherapy, 2013
Else Marie Agger speaks to Katie Lockwood, Assistant Commissioning Editor Else Marie Agger was appointed Director of the Department of Infectious Disease Immunology, Statens Serum Institut in Denmark in 2011. Prior to this, she had been heading two different …